ArticleJournal of managed care & specialty pharmacy2017

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

No numbers read from the abstract.

Not cited yet